7733 Stock Overview
Manufactures and sells precision machineries and instruments worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 7733 from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Olympus Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,855.00 |
| 52 Week High | JP¥2,867.00 |
| 52 Week Low | JP¥1,443.00 |
| Beta | 0.54 |
| 1 Month Change | -2.70% |
| 3 Month Change | -9.38% |
| 1 Year Change | -25.01% |
| 3 Year Change | -33.27% |
| 5 Year Change | -6.19% |
| Change since IPO | 453.73% |
Recent News & Updates
Recent updates
Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 16
Does This Valuation Of Olympus Corporation (TSE:7733) Imply Investors Are Overpaying?
Apr 22The Returns At Olympus (TSE:7733) Aren't Growing
Apr 07Investors Appear Satisfied With Olympus Corporation's (TSE:7733) Prospects
Mar 22These 4 Measures Indicate That Olympus (TSE:7733) Is Using Debt Reasonably Well
Feb 01A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)
Jan 17
Cloud-Powered Endoscopy Innovation Fuels Revenue Growth In The Medical Devices Industry
Approval of AI endoscopy devices in the U.S. and Europe is expected to drive revenue growth through improved clinical outcomes and procedural efficiency.Olympus' (TSE:7733) Strong Earnings Are Of Good Quality
Nov 15Olympus Corporation's (TSE:7733) Share Price Could Signal Some Risk
Nov 07Olympus (TSE:7733) Hasn't Managed To Accelerate Its Returns
Oct 12A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)
Sep 27Does Olympus (TSE:7733) Have A Healthy Balance Sheet?
Jul 14Estimating The Fair Value Of Olympus Corporation (TSE:7733)
Jun 28Shareholder Returns
| 7733 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 2.4% | -1.6% | 2.3% |
| 1Y | -25.0% | -10.1% | 1.8% |
Return vs Industry: 7733 underperformed the JP Medical Equipment industry which returned -10.1% over the past year.
Return vs Market: 7733 underperformed the JP Market which returned 1.8% over the past year.
Price Volatility
| 7733 volatility | |
|---|---|
| 7733 Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in JP Market | 9.3% |
| 10% least volatile stocks in JP Market | 3.0% |
Stable Share Price: 7733 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 7733's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 28,838 | Yasuo Takeuchi | www.olympus-global.com |
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services.
Olympus Corporation Fundamentals Summary
| 7733 fundamental statistics | |
|---|---|
| Market cap | JP¥2.09t |
| Earnings (TTM) | JP¥117.80b |
| Revenue (TTM) | JP¥997.33b |
Is 7733 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7733 income statement (TTM) | |
|---|---|
| Revenue | JP¥997.33b |
| Cost of Revenue | JP¥313.64b |
| Gross Profit | JP¥683.70b |
| Other Expenses | JP¥565.90b |
| Earnings | JP¥117.80b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 08, 2025
| Earnings per share (EPS) | 104.45 |
| Gross Margin | 68.55% |
| Net Profit Margin | 11.81% |
| Debt/Equity Ratio | 30.5% |
How did 7733 perform over the long term?
See historical performance and comparisonDividends
Does 7733 pay a reliable dividends?
See 7733 dividend history and benchmarks| Olympus dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 05 2025 |
| Days until Ex dividend | 66 days |
| Days until Dividend pay date | 3 days |
Does 7733 pay a reliable dividends?
See 7733 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/31 12:14 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Olympus Corporation is covered by 30 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Warren Lau | Aletheia Analyst Network Limited |
| Masahiro Nakanomyo | Barclays |
| Kunihiko Kanno | BNP Paribas Securities (Asia) |